Our study combined our cohort with nine additional cohorts to investigate the potential functional involvement of FA pathway gene expression and mutations in the clinical traits of patients with MDS (n = 1024) and AML (n = 3235) using various research strategies. This evidence concerns the gene FANCA and myelodysplastic syndrome.